Advanced Treatments Create New Prospects for Patients and Their Healthcare Providers New FDA-approved medical treatments can be transformative for patients and families, often providing them with more ...

Performed for the first time ever at the nationally significant hospital "San Pio" in Benevento, led by general director ...

A procedure at Arnot Health is looking to help patients who are dealing with breathing issues and is said to be an option in addition to inhalers and medical transplants. The procedure is called ...

Pulmonx Corporation’s LUNG share price has dipped by 5.09%, which has investors questioning if this is right time to buy.

Pulmonx is known for its minimally invasive treatments for chronic obstructive pulmonary disease (COPD), including products like the Zephyr® Endobronchial Valve, which has received FDA pre-market ...